VOLUNTARY ANNOUNCEMENT INSILICO MEDICINE AND CMS ENTER INTO AN ADDITIONAL DRUG DEVELOPMENT COLLABORATION IN THE FIELDS OF CENTRAL NERVOUS SYSTEM DISEASES